LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inh…
뉴스와이어신상품
0
23
0
11시간전
SAN DIEGO--(Business Wire/Korea Newswire)--LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to h...
